Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0779
    -0.0014 (-0.13%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2623
    +0.0001 (+0.01%)
     
  • USD/JPY

    151.3410
    -0.0310 (-0.02%)
     
  • Bitcoin USD

    70,009.68
    -354.35 (-0.50%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

LED Medical Diagnostics Enters Into Agreement With OrthoSynetics

Preferred-Supplier Status Brings New Opportunities in Orthodontic Imaging Market

ATLANTA, GA--(Marketwired - April 09, 2015) - LED Medical Diagnostics Inc. ("LED Medical" or "the Company") (TSX VENTURE: LMD) (LEDIF) (LME.F) has announced a new agreement with OrthoSynetics, a leading provider of administrative, marketing, and financial services to 350 orthodontic practices across the United States. The agreement designates LED Medical Diagnostics Inc.'s subsidiary LED Dental as the preferred imaging technology supplier for OrthoSynetics.

Under the terms of the agreement, OrthoSynetics clients will have access to exclusive pricing on imaging solutions from LED Dental, including the award-winning Rayscan Alpha imaging system from RAY, a former subsidiary of Samsung. While customers of OrthoSynetics benefit from the new group pricing incentive, LED Dental sees this development as a new avenue for expanding their market share in the orthodontic space.

"We entered the orthodontic imaging market at the American Association of Orthodontists Annual Session in 2014 and immediately recognized the potential to serve this specialty," said Dr. Jeffrey Brooks, vice president of imaging for LED Dental. "We have already worked with several OrthoSynetics clients to implement the Rayscan Alpha imaging system in their practice and look forward to helping additional orthodontists realize the treatment benefits of exceptional imaging technology."

Dr. Jack Devereux and Dr. Phuong Nguyen of Devereux & Nguyen Orthodontics in Metairie, LA are two of the first OrthoSynetics clients to work with LED Dental to bring new imaging technology into their practice. Additionally, both doctors have become Key Opinion Leaders (KOLs) for LED Dental. "We are very proud to be working with the LED Dental team to provide clinical feedback on these imaging solutions," said Dr. Jack Devereux. "It's great to be at the forefront of technological innovation and it's exciting to have input into current and future products."

The OrthoSynetics team prides themselves on helping their clients achieve long-term growth and profitability for their practices. "Working with companies like LED Dental allows us to bring new technologies to our clients at a great value, which is what our company is all about," said John O'Brien, vice president of procurement for OrthoSynetics. "In the end, we want our customers to continuously grow their practices and create successful businesses. Working with suppliers like LED Dental reinforces the value of being an OrthoSynetics client."

"The orthodontic community is a large market segment that is vital to the success of LED," concludes Dr. David Gane, CEO of LED Medical Diagnostics Inc. "Entering into this agreement with OrthoSynetics pairs us with a similar white-glove service organization in the dental technology space and furthers our goal of being the leading provider of digital imaging technologies across the dental industry. This relationship is an excellent example of the type of efficient and synergistic scale-up opportunities that we'll look to find and execute as a part of our broader growth strategy."

For more information about LED Dental or the Rayscan Alpha imaging system, please visit www.leddental.com. For details on the services provided by OrthoSynetics, go to www.orthosynetics.com.

About LED Medical Diagnostics Inc.

Founded in 2003 and headquartered in Burnaby, British Columbia, Canada, LED Medical Diagnostics Inc., through its wholly-owned subsidiaries LED Dental Inc. and LED Dental Ltd, provide dentists and oral health specialists with advanced diagnostic imaging products and software, in addition to the award-winning VELscope® Vx tissue fluorescence visualization technology. Backed by an experienced leadership team and dedicated to a higher level of service and support, LED Dental is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio.

The Company is currently listed on the TSX Venture Exchange (TSX-V) under the symbol "LMD", the OTCQX under the symbol "LEDIF", as well as the Frankfurt Stock Exchange under the symbol "LME". For more information, call 844.952.7327 or visit www.leddental.com/investor-relations.

About OrthoSynetics

OrthoSynetics provides its members with a comprehensive service unlike any other in the industry. A team of business experts help your practice in the following service areas: marketing, purchasing, patient benefit & eligibility verification, collections, human resources, real estate & facilities management, tech support, and practice consulting & education. All of these services under one roof and working together to better your practice is one of the many reasons more orthodontist are choosing OrthoSynetics than ever before.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward Looking Statements
This press release contains statements which, to the extent that they are not recitations of historical fact, may constitute forward-looking information under applicable Canadian securities legislation that involve risks and uncertainties. Such forward-looking statements or information include statements regarding, but not limited to the Company's future growth strategy, its distribution strategy and product offerings, potential expansion of the Company's technology to other medical applications or markets, or the potential introduction of new technologies by the Company. Persons reading this press release are cautioned that such statements or information are only predictions, and that the Corporation's actual future results or performance may be materially different. Factors that could cause actual events or results to differ materially from those suggested by these forward-looking statements include, but are not limited to competition risks, distributor risks, product development risks such as regulatory, design, intellectual property and other factors described in the Corporation's reports filed on SEDAR including its Annual Information Form and financial report for the year ended December 31, 2013. These and other factors should be considered carefully and readers should not place undue reliance on such forward-looking information. All forward-looking statements made in this press release are qualified by this cautionary statement and there can be no assurance that actual results or developments anticipated by the Company will be realized. The Company disclaims any intention or obligation to update or revise forward-looking information, whether as a result of new information, future events or otherwise, except as required by law.

Advertisement